A Pilot study to evaluate the efficacy of prophylactic BiPAP/CPAP ventilation for the prevention of acute mountain sickness in non-acclimatized individuals
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 38
- 试验地点
- 1
- 主要终点
- this is pilot trial to evaluate the efficacy of non invasive ventilation for the prevention of the acute mountain sickness in those people who are not acclimatized
研究概览
简要总结
Altitude sickness results from a rapid change in air pressure and air oxygen levels at higher elevations. You may have symptoms if you travel to a high elevation without giving your body time to adjust to less oxygen.
Acetazolamide is one of the medications for the prevention and treatment of altitude sickness. It increases the breathing rate allowing more oxygen to be taken in. This helps the body adjust to higher altitudes faster and reduces some of the symptoms of altitude sickness.
patient who did not get relieved by preventive dose of the tablet dimox, has been given the oxygen supplimentation
研究设计
- 研究类型
- Interventional
- 分配方式
- Computer generated randomization
- 盲法
- Participant and Investigator Blinded
入排标准
- 年龄范围
- 18.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •adult male and female of age not more than 60 years, who visited high altitude zone.
排除标准
- •any coronary artery disease any respiratory disease hypertensive diabetic tubercular treatment bleeding disorder.
结局指标
主要结局
this is pilot trial to evaluate the efficacy of non invasive ventilation for the prevention of the acute mountain sickness in those people who are not acclimatized
时间窗: 6, 12 and 24 hours
次要结局
- effect of the dimox tablet(6,12 and 24 hrs)